Recent Posts
- Should You Make After-Tax, Non-Roth 401(k) Contributions?
- The Business Lifecycle Part 3: The Growth Stage
- Managing Overhead Costs Today
- Midyear is a Good Time to Update Your Business’s Strategic Plan
- The Pros and Cons of Alternative Investments for Nonprofits
- The Audit Findings That Never Seem to Go Away – And How Municipalities Can Fix Them
- Looking for Funding? Consider SBA Loans
- Protect Yourself From Fraudsters Impersonating the IRS and Other Tax Scams
-

IRS Releases Guidance on Changes to R&E Expensing
Among its numerous tax provisions, the One Big Beautiful Bill Act (OBBBA) reinstated immediate deductions for research and experimental (R&E) expenditures under Internal Revenue Code Section 174, beginning in 2025. The…
-

Is Your Company’s Pricing Strategy Still Viable?
Pricing is among the most powerful levers for business owners to calibrate their companies’ profitability. Set prices too low and you risk leaving money on the table. Set them too…
-

The Payroll Implications of the One Big Beautiful Bill Act: What We Currently Know
The One Big Beautiful Bill Act (OBBBA), signed into law on July 4, 2025, has impacted many areas of taxation, including individual, business, and payroll taxes. As of September 2025,…
-

Delisting Decisions: The Complex Road to Going Private
U.S. public companies may decide to delist — or “go private” — for various strategic and financial reasons. For example, chain retailer Walgreens recently finalized a private equity deal worth…
-

New Rules Could Boost Your R&E Tax Savings in 2025
A major tax change is here for businesses with research and experimental (R&E) expenses. On July 4, 2025, the One Big Beautiful Bill Act (OBBBA) reinstated the immediate deduction for U.S.-based…
